BlackRock Institutional Trust’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
PAI
BFA
EWM
JSP
BlackRock Institutional Trust's ABMD Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Abiomed Inc (ABMD) stake by 4.4% in Q4 2016, buying an estimated $6.03M and bringing the position to 1,229,259 shares worth $139M. The position accounts for 0.02% of the portfolio, ranked #750.
BlackRock Institutional Trust first reported a position in ABMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $151M in Q3 2016. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.
- BlackRock Institutional Trust held 1,229,259 shares of Abiomed Inc worth $139M as of Q4 2016.
- BlackRock Institutional Trust bought 52,061 Abiomed Inc shares in Q4 2016, an estimated $6.03M.
- Abiomed Inc made up 0.02% of BlackRock Institutional Trust's portfolio in Q4 2016, its #750 holding.
- BlackRock Institutional Trust first reported a position in Abiomed Inc in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Abiomed Inc position peaked at $151M in Q3 2016.
- 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.